JPS5931745A - Ｌ―アラニル―ｄ―イソグルタミンアダマンチルアミド及びその製造方法 - Google Patents

Ｌ―アラニル―ｄ―イソグルタミンアダマンチルアミド及びその製造方法

Info

Publication number
JPS5931745A
JPS5931745A JP58112956A JP11295683A JPS5931745A JP S5931745 A JPS5931745 A JP S5931745A JP 58112956 A JP58112956 A JP 58112956A JP 11295683 A JP11295683 A JP 11295683A JP S5931745 A JPS5931745 A JP S5931745A
Authority
JP
Japan
Prior art keywords
isoglutamine
adamantylamide
alanyl
effect
mdp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP58112956A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0352478B2 (enExample
Inventor
マルテイン・フレゲル
ミラン・クロイドロ
イリ・コリンスキイ
カレル・マセク
ヤロスラフ・セイフエルト
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Spofa Spojene Podniky Pro Zdravotnickou Vyrobu
Original Assignee
Spofa Spojene Podniky Pro Zdravotnickou Vyrobu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spofa Spojene Podniky Pro Zdravotnickou Vyrobu filed Critical Spofa Spojene Podniky Pro Zdravotnickou Vyrobu
Publication of JPS5931745A publication Critical patent/JPS5931745A/ja
Publication of JPH0352478B2 publication Critical patent/JPH0352478B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP58112956A 1982-06-29 1983-06-24 Ｌ―アラニル―ｄ―イソグルタミンアダマンチルアミド及びその製造方法 Granted JPS5931745A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CS824908A CS231221B1 (en) 1982-06-29 1982-06-29 L-alanyl-d-isoglutamine adamantylamide
CS4908-82 1982-06-29

Publications (2)

Publication Number Publication Date
JPS5931745A true JPS5931745A (ja) 1984-02-20
JPH0352478B2 JPH0352478B2 (enExample) 1991-08-12

Family

ID=5392849

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58112956A Granted JPS5931745A (ja) 1982-06-29 1983-06-24 Ｌ―アラニル―ｄ―イソグルタミンアダマンチルアミド及びその製造方法

Country Status (9)

Country Link
US (1) US4515715A (enExample)
EP (1) EP0098520B1 (enExample)
JP (1) JPS5931745A (enExample)
AT (1) ATE17652T1 (enExample)
CS (1) CS231221B1 (enExample)
DD (1) DD217210A1 (enExample)
DE (1) DE3362009D1 (enExample)
HU (1) HU194911B (enExample)
MX (1) MX156864A (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS231221B1 (en) * 1982-06-29 1984-10-15 Martin Flegel L-alanyl-d-isoglutamine adamantylamide
FR2572399B1 (fr) * 1984-10-31 1987-01-16 Panmedica Sa Nouveaux derives de l'adamantanamine, leurs procedes de preparation et medicaments les contenant
YU30589A (en) * 1989-02-09 1991-10-31 Imunoloski Z Zagreb New adamantyl containing tripeptides and it's hydrochloride and process for preparing and use
IT1264129B1 (it) * 1993-04-09 1996-09-16 Codev S A Peptidi ad attivita' immunomodulatoria derivati da frammenti di leucochinina
AU4251300A (en) 1999-05-07 2000-11-21 University Of Virginia Patent Foundation Biological production of stable glutamine, poly-glutamine derivatives in transgenic organisms and their use for therapeutic purposes
WO2005016959A1 (en) * 2003-08-13 2005-02-24 Pepharm R & D Limited Biologically active peptides comprising phenylalanyl-glutamate (fe) and phenylalanyl-glutamyl-glutamate (fee)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2482957A2 (fr) * 1979-06-29 1981-11-27 Rhone Poulenc Ind Nouveaux dipeptides, leur preparation et les medicaments qui les contiennent
US4273704A (en) * 1979-12-03 1981-06-16 G. D. Searle & Co. N-Adamantane-substituted tetrapeptide amides
CS231221B1 (en) * 1982-06-29 1984-10-15 Martin Flegel L-alanyl-d-isoglutamine adamantylamide

Also Published As

Publication number Publication date
CS490882A1 (en) 1984-02-13
EP0098520B1 (de) 1986-01-29
JPH0352478B2 (enExample) 1991-08-12
US4515715A (en) 1985-05-07
ATE17652T1 (de) 1986-02-15
DD217210A1 (de) 1985-01-09
MX156864A (es) 1988-10-07
HU194911B (en) 1988-03-28
EP0098520A1 (de) 1984-01-18
DE3362009D1 (en) 1986-03-13
CS231221B1 (en) 1984-10-15

Similar Documents

Publication Publication Date Title
JP4923216B2 (ja) 化合物
AU2015277312B2 (en) Synthesis of polycyclic-carbamoylpyridone compounds
SU1190990A3 (ru) Способ получени производных мурамилдипептида
CN114292272A (zh) 一种核苷类化合物及其用途
WO1995009864A1 (en) Novel peptide derivative
CA2082216A1 (en) Polycyclic conjugates
HUP9902181A2 (hu) Immunomoduláló hatással rendelkező acilezett N-(hidroxi-metil)-thalidomid prodrugok
SE447389B (sv) Nya tripeptider, som inverkar pa det centrala nervsystemet
CN121652220A (zh) 含有三氟甲磺酰基的化合物
JPS5931745A (ja) Ｌ―アラニル―ｄ―イソグルタミンアダマンチルアミド及びその製造方法
US20080194801A1 (en) Robust multidentate ligands for diagnosis and anti-viral drugs for influenza and related viruses
JP2019515014A (ja) セコマクロライド化合物
CA1059994A (en) Histidine derivatives
WO2003106481A1 (en) A process of producing ala-glu dipeptide
JPS61100564A (ja) ペプチドで置換された複素環免疫促進剤
CN110204537B (zh) 一种用作吲哚胺2，3-双加氧酶的抑制剂的1，2，5-噁二唑衍生物
PT91235B (pt) Processo para a preparacao de novos inibidores da s-adenosil-metionina-descarboxilase
US7365055B2 (en) Derivatives of morphine-6-glucuronide, pharmaceutical compositions containing them, their preparation method and their uses
Kurokawa et al. A solid-phase synthesis for β-turn mimetics of sialyl Lewis X
JP2006502975A (ja) 化学物質または熱刺激または侵害受容体炎症媒介物に対する応答を阻害することのできる化合物、該化合物を得る方法、および該化合物を含む組成物
CN117164600A (zh) 一种ADC药物毒素伊沙替康衍生物Dxd的制备方法
CA1206958A (en) L-alanyl-d-isoglutamine adamantylamide
JPH11501043A (ja) Ｎｏシンターゼの阻害剤として活性を有するアルギニン類縁体
CN118894838B (zh) 一种酰胺衍生物及其制备方法和应用
WO1991011444A1 (en) Piperazine compound, production thereof, and medicinal use thereof